An 18-plex assay has been developed for the simultaneous detection of Bacillus anthracis, Yersinia pestis, Francisella tularensis, Brucella abortus, Brucella melitensis, and Salmonella enterica. The assay contains three signatures (ie: primer/probe triplets) for the detection of Bacillus anthracis (one signature targeting the chromosome of the agent, one signature targeting pXO1, and one signature targeting pXO2), four signatures for the detection of Yersinia pestis (one signature targeting the chromosome and one signature targeting each of 3 plasmids), two signatures for the detection of Francisella tularensis (both chromosomal signatures), one signature for Brucella abortus (targeting the chromosome), two signatures for Brucella melitensis (targeting the chromosome), and two signatures for the detection of Salmonella enterica (both signatures target specific virulence genes in virulent Salmonella enterica strains). The assay includes a positive control signature targeting an externally added template (Erwinia herbicola genomic DNA), a negative control signature targeting Thermotoga maritime [Tm] (a bacterium found in deep ocean vents), an instrument control signature consisting of the Tm probe with Cy-3 moieties attached to one bead class, and a fluorescence control consisting of a Tm probe with multiple biotin moieties attached to one bead class.
Four candidate Salmonella enterica signatures were incorporated into the previous version of the assay (Panel 3) and tested to select the best signatures to integrate. Two of the four signatures were removed for high backgrounds and cross-reactivity within the multiplex. The remaining two signatures were incorporated into the new "Panel 4" assay to move forward with for further testing.
Limit of detection (LOD) with a confidence interval of 95% or greater for each signature by copy number (determined using artificially generated template nucleic acids incorporated into each of 15 plasmids and spiked in combination into each reaction) is summarized in Table 1. Assay sensitivity and selectivity studies concluded that the assay can provide confirmatory detection (i.e.: multiple assay signatures targeting different sections of agent genome generating Median Fluorescence Intensities [MFI] above threshold) for the vast majority of target genomes tested.
In tests exploring potential cross-reactivity with over 200 background and near-neighbor templates at high spikes, two near-neighbor templates were found to cross-react with both newly incorporated Salmonella enterica signatures. Salmonella enterica salamae (MZ1440) showed that it will cross react with both Salmonella signatures (S1 and S2) in the multiplex. Salmonella enterica houtanae IV (MZ1442) also displayed a very weak cross reactivity with one of the two Salmonella signatures (S1) within in the multiplex as well. [Ft1 (Ft9941) ] also demonstrated some cross-reactivity with various soils, eukaryotes, and microbes which are detailed in the Cross-Reactivity Study Results section. Table 1   Table 1 : Signature names are listed with their genome target regions and the LLNL-assigned signature number in order to facilitate cross-referencing. Tests were conducted using multiple plasmids, each containing the target region of each signature, simultaneously spiked into reactions and titrated over 8 logs. Each reaction was repeated 20 times and a signal above threshold (Thresholds set using a minimum of 700 data points with a 2% maximum false positive rate per signature) in at least 19 of 20 cases indicated an LOD point with a confidence interval of 95% or greater.
Furthermore, tests on high concentrations of total nucleic acid extracts from 32 soil samples collected from across the continental United States, 45 bacterial samples taken from Lawrence Livermore National Laboratory (LLNL) stocks as well as those purchased from the American Type Culture Collection (Manassas, VA) and other vendors, 16 eukaryotic organisms (purchased from various vendors), and 11 cell culture extracts (generate at LLNL) demonstrated minimal cross-reactivity with these materials (see Cross-Reactivity Study Results section). It is anticipated that with guidance from FDA CFSAN, additional tests including those conducted in food matrices may also be appropriate, or the FDA CFSAN may choose to conduct its own cross-reactivity tests once the assay panel becomes available to them.
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Materials and Methods (General Description):
All reactions were carried out on 96 well PCR plates (Accuflow, E&K Scientific, Santa Clara, CA) in a total volume of 25μL (20μL master mix plus 5μL sample) optimized for multiplexed PCR. A volume of 20μL PCR master mix (Maxima Hot Start PCR Master Mix (2x) -500 reactions, Cat# K1052, Thermo Fisher Scientific Biosciences, Lafayette, CO) contains: 12.5μL 2X PCR Master Mix, 3μL 15-plex primer mix (0.4 mM final concentration each forward and reverse primer), 0.5μL Erwinia herbicola DNA (positive control) at 2.5 pg/reaction, and 4μL of PCR grade water (Ambion, Austin, TX). Forward primers were biotinylated with a single biotin moiety at the extreme 5' end of each primer while Reverse primers were unmodified. Probes had a C-18 spacer at the 3'end with a carboxyl moiety at the end of the C-18 spacer. All oligonucleotides were purchased as high purity reagents (90% or better purity guarantee) from BioSearch Technologies, Novato, CA. Master mixes were prepared inside of a PCR Workstation (AirClean ® Systems AC600 PCR Hood Series, Raleigh, NC). Master mix material was loaded on to 96-well PCR plates and transferred to a second PCR Workstation for template addition and sealing of plates. Sealed plates were then spun at 1000 rpm in a plate centrifuge for one minute in order to ensure complete addition of any reagents stuck to sides of plate wells and transferred to a thermocycler (MJ Research-Now BioRad Inc., Hercules, CA). PCR cycling was carried out as shown in Table 2 . Upon completion of thermal cycling, plates were removed and spun a second time as described to reduce potential for cross-contamination of wells by condensate droplets adhering to film.
Following PCR amplification, 5μL of PCR product was added to 22μL of microbead mixture. Unconjugated beads supplied by Luminex Corp. (Austin, TX). The amplified product was denatured at 95°C for 2 minutes, hybridized at 55C for 5 minutes, and immediately removed from the 96-well heated thermocycler. Following hybridization, 100μL of heated (55˚C) Tris-NaCl buffer was added to the hybridized oligo-bead reactions and this mixture was transferred to a pre-wetted 96-well filter bottom plate, 1.2µm pore size (Millipore Corp., Billerica, MA). The hybridized oligo-bead reactions on the filter plate were washed twice with heated (55˚C) 100 μL Tris-NaCl to remove unhybridized nucleic acids. The PCR products bound to the beads were labeled by adding 60μL SAPE (Streptaviden Rphycoerythrin conjugate 3 ng/μL (Moss, Inc; Pasadena, MD) and were incubated in the dark for 5 minutes. Beads were washed once with heated (55˚C) 100 μL Tris-NaCl, re-suspended in 100μL TrisNaCl and analyzed using Bio-Plex 100 ® (Bio-Rad Laboratories, Hercules, CA) instrument.
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Results:
As previously reported (see Year 1 and Year 3 reports) and as shown in Table 3 , from an initial pool of 43 pathogen-specific signatures, 13 were down-selected for incorporation into the multiplex panel. For the introduction of Salmonella enterica signatures to Panel 3, 2 signatures were down-selected for incorporation into the multiplex panel from an initial pool of 4 signatures targeting virulence factors found in virulent Salmonella enterica strains, as shown in Table 3 .1. Four factors eliminated a signature from consideration for incorporation into the multiplex: High MFIs when tested on water blank samples (see High Backgrounds in Table 3 ); Cross-reactivity with one or more other agents; lack of reactivity, or poor reactivity with target templates. Although each of these signatures performed well in singleplex reactions, upon incorporation into the multiplex panel, these issues were observed with two of the four signatures. The down-selected signatures incorporated into the multiplex panel did not suffer these limitations. S1 (prgI_v2_3) and S2 (ssaV_v2_10) are two signatures targeting virulence genes in virulent Salmonella enterica strains. Both signatures have a granular LOD of 1000 copies/reaction when tested against synthetic plasmid templates. One issue we have run across with the multiplex was during the background and near neighbor testing. Both S1 and S2 showed reactivity against Salmonella enterica salamae (MZ1440). S1 showed weak reactivity against Salmonella enterica houtanae IV (MZ1442). It is suspected (but not tested) that these two strains both carry the prgI gene and that Salmonella enterica salamae (MZ1440) also carries the ssaV virulence gene. Yp1 (Yp2040) and Ft1 (Ft9941) signatures showed some cross reactivity (2 of 3 or 3 of 3 replicates) with 5 soil samples, while the S1 signature showed some cross-reactivity (2 of 3 replicates) with Bacillus subtilis . The data is summarized on tables 15-16.1 of this report.
One other potential issue is with Yp2 (Yp4683). This signature's response showed a decrease in MFI compared with Panel 3 data with the switch to the Thermofisher Maxima enzyme. While the granular LOD remained 1000copies/reaction, the overall endpoint MFI response of the signature has changed. The signature is still within acceptable limits of detection.
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High Backgrounds Cross Reactivity Lack of Reactivity

0000
FAIL
0012
FAIL
0051
FAIL
9941
PASS
9983
PASS
6133
FAIL
6126
FAIL
6132
PASS
6135
FAIL
6144
FAIL
6147
FAIL
6201
FAIL
6116
FAIL
6118
FAIL
6130
FAIL
6125
FAIL
6115
PASS
6120
FAIL
9469
FAIL
9489
FAIL
9472
FAIL
9478
FAIL
9485
PASS
9496
FAIL
1994
FAIL
1996
FAIL
2006
FAIL
2007
FAIL
2008
FAIL
2009
FAIL
2034
FAIL
2036
FAIL
2003
FAIL
2010
FAIL
2011
FAIL
2014
FAIL
2018
FAIL
2040
PASS
5554
PASS
5564
FAIL
5574
FAIL
5577
FAIL
4698
FAIL
4705
FAIL
4683
PASS
9078
FAIL
9147
FAIL
8989
PASS
Thresholds:
Thresholds for discrimination of positive from negative signals were set using over 700 negative data points for each signature. Data from tests conducted using various targets, near-neighbors, and background nucleic acid extracts were compiled into receiver operating characteristic (ROC) curves. A ROC curve is a graphical plot of the sensitivity or true positive rate vs. false positive rate for a binary classifier system such as the one we are trying to develop here to discriminate positive from negative signals.
Median Fluorescence Intensities (MFIs) corresponding to a positive signal were calculated for each signature based on the compilation of signals from a minimum of 1000 negative reactions. A negative reaction was defined as any test where the template for that particular signature was not present. Thus, for each Yp targeting signature, all background extracts such as soils, prokaryotes, and eukaryotes as well as target tests using Ft or Ba templates were considered as negative reactions. From the compiled signals from over 700 negative reactions, MFIs were assigned using only the 95% upper confidence interval for MFIs at the 98 th percentile value. Thus, signature thresholds were set such that a false positive signal would not be expected in greater than 2% of all tests using this multiplex assay. Furthermore, we can say with confidence in excess of 95% that we will never see a false positive rate for any of the signatures in this multiplex panel greater than 2%. The thresholds thus generated are listed in Table 4 . The thresholds used to determine LOD were conservatively rounded up to an MFI of 50 (unless already above an MFI of 50) to prevent the threshold from being too low as to be seen as normal background.
Please note that as additional data is generated using this multiplex assay, these thresholds can be reset at the users' discretion in order to increase or decrease sensitivity with concomitant increase or decrease in false positive rates respectively in order to accommodate case for use.
Limits of Detection on Whole Agent Targets:
Initial limit of detection determinations were conducted using total nucleic acid extracts from one strain of each target organism in triplicate over an 8-log titration spanning 10pg/reaction to 1attogram/reaction. Titration curves (MFI vs. a log-titration series of decreasing amounts of genomic template) for each of the three agents are shown in Figures 1-6. As each signature represents an independent PCR reaction, each signature has a threshold that is set independently as observed from Figures 1-3 and Table 4 . This is significant as it means that there is no significant cross-hybridization or cross-reaction between 
Studies to Determine Assay Applicability to Many Strains of Target Organisms:
In order to test the sensitivity and applicability of the assay for detection of multiple strains of each agent, total nucleic acid extracts from 2 strains of each target agent were tested at 0.1pg/reaction, 1pg/ reaction, and 10pg/reaction. The results of those tests are summarized in Tables 5-9. Table 10 shows the 5 different Salmonella enteria templates that were tested with the Year 4 multiplex panel. 
Cross-Reactivity Studies:
In order to determine the potential for the assay to cross-react with environmental nucleic acids, from other prokaryotes, eukaryotes, and near-neighbor organisms, seven panels of total nucleic acid extracts were used in triplicate reactions. For Year 4 near neighbor testing, 10 near neighbors were tested at 100pg/rxn spikes. The panels of templates used and results are summarized in tables 11-16 and results are reported below each table. 
Cytophaga marinoflava Paenibacillus napthalaenovorans Vibrio paraheamolyticus Erwina amylovora Paracoccus dentrificans Xanthomonas translucens
The prokaryotic templates used were a collection of extracts generated at LLNL and other templates purchased from commercial vendors. Each test contained 100pg of the total nucleic acid extract spiked into each reaction. All signals for all of the signatures were reproducibly below established thresholds for all templates in this panel.
Table 12 List of Eukaryotic Organisms Used for Assay Cross-Reactivity Studies
The eukaryotic templates used were a collection of total genomic nucleic acids purchased from commercial vendors. Each test contained 5ng of the total nucleic acid extract spiked into each reaction. All signals for all of the signatures were reproducibly below established thresholds for all templates in this panel. Total nucleic acid extracts were generated at LLNL from soil samples collected from 54 locations across the United States. These soils had been collected from urban, suburban, and rural environments. Each soil sample is curated with detailed information as to location, time of day, flora and fauna present at the collection site, etc. Each test contained 5ng of total nucleic acid spiked into each reaction. Two signatures (Yp2040 and Ft9941) showed cross-reactivity or random spikes against various backgrounds (soils, microbes, and eukaryotes). Yp2040 was the only signature to show true (3 out of 3) cross reactivity with 3 different soils (S286, S287, and D000405 #53). The new enzyme is more robust in terms of amplification so the cross-reactivity in previous panels may have been present but not over the set threshold for that panel. Streptomyces scabei 1 out of 3 (512) Tick 1 out of 3 (293) S1 (prgI_v2_3) Bacillus subtilis 2 out of 3 (247) The Year 4 multiplex panel was tested against 10 Near Neighbor templates as seen below: A total of 10 near neighbors were tested against the Panel 4 multiplex. Salmonella enterica salamae MZ1440 cross-reacted with both S1 and S2 signatures. This is an indication that the near neighbor used has picked up, at some point, both the S1 and S2 virulence genes. This cross-reactivity was also noted during the TTA1 (Technical Tropic Area 1, Department of Homeland Security) TaqMan development work (Table 16 .1). Weak reactivity was noted for S1 against Salmonella enterica houtanae IV MZ1441 but not for S2 in the multiplex testing.
In conclusion, actual cross-reactivity (3 out of 3 tests) was observed only for Yp1 (2040) against three different soils (S286, S287, D000402 #53) based on the established thresholds for the Panel 4 multiplex. Random spikes were noted but are not considered true cross-reactive templates as they only spiked once or twice when tested in triplicate. In order to determine whether or not these are true reactives or if there is true cross-reactivity with off-target nucleic acids in the soil, it would be necessary to sequence the amplicons resulting from these reactive samples. Then, if the amplicon generated was the target amplicon, the designation of cross-reactive would not be quite accurate and would mean that the target for the signature is present in these soil samples. However, if the sequences generated were those intended, then further investigation is needed.
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Limit of Detection Studies Utilizing Artificial Templates:
In order to determine copy number sensitivity for each signature, multiple plasmids, each containing the full amplicon region of each signature were generated by BioSearch Technologies (Novato, CA), the sequences of those inserts verified, and the plasmids used in combination for our limit of detection studies. Briefly, each plasmid was quantitated using spectrophotometry after linearization with a single cut enzyme. All plasmids for each agent (i.e.: 2 plasmids for Ft, 3 plasmids for Ba, 3 plasmids for Bru, 4 plasmids for Yp, and 2 plasmids for Salmonella) were mixed in equimolar amounts and a titration series conducted for LOD determination. Titration response curves for each signature are shown in Figures 4-12 . signatures were linearized and mixed in equimolar ratios. This material was then titrated over 8 logs from 20,000 copies/μL to 0.002 copies/μL. Triplicate reactions using the multiplex assay were then conducted on each titration point using 5μL of each template titration resulting in a test range of 8 logs from 100,000 copies/ reaction. to 0.01 copy/ reaction. A semilog plot was generated with average MFIs used for the plot and standard deviations shown as error bars. Threshold for this signature is shown as a straight dashed red line. Figure 6 shows a sensitivity of 100 copies per reaction for the Ba1(6132) signature. signatures were linearized and mixed in equimolar ratios. This material was then titrated over 8 logs from 20,000 copies/μL to 0.002 copies/μL. Triplicate reactions using the multiplex assay were then conducted on each titration point using 5μL of each template titration resulting in a test range of 8 logs from 100,000 copies/ reaction. to 0.01 copy/ reaction. A semilog plot was generated with average MFIs used for the plot and standard deviations shown as error bars. Threshold for this signature is shown as a straight dashed red line. Figure 7 shows a sensitivity of 100 copies per reaction for the Ba2 (6115) signature. signatures were linearized and mixed in equimolar ratios. This material was then titrated over 8 logs from 20,000 copies/μL to 0.002 copies/μL. Triplicate reactions using the multiplex assay were then conducted on each titration point using 5μL of each template titration resulting in a test range of 8 logs from 100,000 copies/ reaction. to 0.01 copy/ reaction. A semilog plot was generated with average MFIs used for the plot and standard deviations shown as error bars. Threshold for this signature is shown as a straight dashed red line. Figure 8 shows a sensitivity of 10 copies per reaction for the Ba3(9485) signature. signatures were linearized and mixed in equimolar ratios. This material was then titrated over 8 logs from 20,000 copies/μL to 0.002 copies/μL. Triplicate reactions using the multiplex assay were then conducted on each titration point using 5μL of each template titration resulting in a test range of 8 logs from 100,000 copies/ reaction. to 0.01 copy/ reaction. A semilog plot was generated with average MFIs used for the plot and standard deviations shown as error bars. Threshold for this signature is shown as a straight dashed red line. Figure 9 shows a sensitivity of 1000 copies per reaction for the Yp1(2040) signature. signatures were linearized and mixed in equimolar ratios. This material was then titrated over 8 logs from 20,000 copies/μL to 0.002 copies/μL. Triplicate reactions using the multiplex assay were then conducted on each titration point using 5μL of each template titration resulting in a test range of 8 logs from 100,000 copies/ reaction. to 0.01 copy/ reaction. A semilog plot was generated with average MFIs used for the plot and standard deviations shown as error bars. Threshold for this signature is shown as a straight dashed red line. Figure 10 shows a sensitivity of 1000 copies per reaction for the Yp2 (4683) signature. signatures were linearized and mixed in equimolar ratios. This material was then titrated over 8 logs from 20,000 copies/μL to 0.002 copies/μL. Triplicate reactions using the multiplex assay were then conducted on each titration point using 5μL of each template titration resulting in a test range of 8 logs from 100,000 copies/ reaction. to 0.01 copy/ reaction. A semilog plot was generated with average MFIs used for the plot and standard deviations shown as error bars. Threshold for this signature is shown as a straight dashed red line. Figure 11 shows a sensitivity of 1000 copies per reaction for the Yp3 (5554) signature. Figure 18 shows a sensitivity of 10 copies per reaction for the S1 (prgI_v2_3) signature. enterica were linearized and mixed in equimolar ratios. This material was then titrated over 8 logs from 20,000 copies/μL to 0.002 copies/μL. Triplicate reactions using the multiplex assay were then conducted on each titration point using 5μL of each template titration resulting in a test range of 8 logs from 100,000 copies/reaction. to 0.01 copy/ reaction. A semilog plot was generated with average MFIs used for the plot and standard deviations shown as error bars. Threshold for this signature is shown as a straight dashed red line. Figure 18 shows a sensitivity of 100 copies per reaction for the S2 (ssaV_v2_10) signature.
In order to ensure that the LODs reported for these assays had sufficient robustness, another set of titrations at and near the initially determined LODs were conducted as before. Here, however, 20 replicates of each reaction were conducted as the final LODs reported had to be within 95% confidence interval (ie: the assay should be expected to deliver at least this LOD 95% of the time or better). S1 (prgI_v2_3) 
